ADAR1 Partners LP 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 08:00 am Purchase |
2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB |
ADAR1 Partners LP | 1,824,063 6.210% |
1,824,063 (New Position) |
Filing |